Commonly reported side effects with the drug were nausea, constipation, itching, rash and headache. "The new medication has side effect profiles that are inherently, not only different ...

has shown promising efficacy as a treatment for chronic constipation in a phase IIb, double-blinded, placebo-controlled, dose-ranging trial. This new therapy could potentially improve symptoms ...

Glenmark Pharmaceuticals has introduced a new constipation treatment, polyethylene glycol 3350 powder, to the US market. This launch aims to fulfill the rising demand for a fresh supplier in the ...

The US medicines regulator approved a new type of pain pill that aims ... Commonly reported side effects with the drug were nausea, constipation, itching, rash, and headache.

Glenmark Pharmaceuticals launches polyethylene glycol 3350, a constipation treatment medicine in the US. The OTC product aims ...

Constipation is more than just "trouble going"—it's a common digestive issue where bowel movements feel infrequent, difficult to pass, or incomplete. Because a variety of symptoms can result ...

New recommendations on diagnosing and ... data are lacking to support their efficacy in those with chronic constipation. If empirical treatment of patients with chronic constipation fails, osmotic ...

Loss of mobility, medications, associated comorbidities ... In laxative resistant constipation, several new agents that target different underlying pathophysiological mechanisms have been proved ...